RxDoctor Payments Data

Matthew Sweney

Neurology with Special Qualifications in Child Neurology · Salt Lake City, UTNPI 1568581551

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in UT, where the typical reported total is $233.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$895,345in research payments, 2019–2025

Across 191 payments — averaging $4687.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Immedica Pharma US, Inc.$289K
  • Takeda Pharmaceuticals U.S.A., Inc.$257K
  • SK Life Science, Inc.$201K
  • Zogenix Inc.$98K
  • UCB, Inc.$19K
  • Jazz Pharmaceuticals Inc.$18K
  • plus $15K from 2 others

How this compares

$0 in reported general payments places this provider in the 0th percentile of 21 neurology with special qualifications in child neurology providers in Utah.

See all neurology with special qualifications in child neurology providers in Utah

Other neurology with special qualifications in child neurology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →